Viva Biotech
Shanghai · Founded 2008
About Viva Biotech
Viva Biotech offers global innovative drug R&D companies one-stop comprehensive services ranging from early structure-based drug R&D to commercial drug delivery. Using its advantages in the field of structure-based drug discovery (SBDD) technology, it provides global partners with CRO services in the new drug research stage and has established X-ray protein crystal technology, cryo-electron microscopy (Cryo-EM), and affinity mass spectrometry screening technology (ASMS), surface plasmon resonance (SPR), hydrogen-deuterium exchange mass spectrometry (HDX-MS), computer-aided drug design, and other advanced technology platforms.
Company Facts
- Founded: 2008
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $100K – $500K
- Total funding: $247.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jun 2023)
- Ticker: sehk:1873
- Website: vivabiotech.com.cn
- Phone: +86(0)21 6089 3288
Industries & Categories
Clinical Trials, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/viva-biotech-38472 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.